These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6890168)

  • 1. Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF.
    Montplaisir J; de Champlain J; Young SN; Missala K; Sourkes TL; Walsh J; Rémillard G
    Neurology; 1982 Nov; 32(11):1299-302. PubMed ID: 6890168
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine interactions in narcolepsy and hypersomnia: reanalysis.
    Faull KF; Thiemann S; King RJ; Guilleminault C
    Sleep; 1989 Apr; 12(2):185-6. PubMed ID: 2711094
    [No Abstract]   [Full Text] [Related]  

  • 3. Narcolepsy and hypersomnia.
    Thal LJ; Sharpless NS
    Neurology; 1983 Oct; 33(10):1394-5. PubMed ID: 6684244
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in hypersomnia with periodic apneas or idiopathic hypersomnia: preliminary results.
    Baruzzi A; Cirignotta F; Coccagna G; Calderini G; Lugaresi E
    Sleep; 1980; 3(3-4):247-9. PubMed ID: 6164086
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
    Faull KF; Thiemann S; King RJ; Guilleminault C
    Sleep; 1986; 9(1 Pt 2):246-9. PubMed ID: 2422716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin concentrating hormone in central hypersomnia.
    Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
    Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin.
    Bassetti CL; Baumann CR; Dauvilliers Y; Croyal M; Robert P; Schwartz JC
    J Sleep Res; 2010 Dec; 19(4):620-3. PubMed ID: 20846244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
    Faull KF; Guilleminault C; Berger PA; Barchas JD
    Ann Neurol; 1983 Mar; 13(3):258-63. PubMed ID: 6189447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal central monoamine metabolism in humans with "true hypersomnia" and "sub-wakefulness".
    Livrea P; Puca FM; Barnaba A; Di Reda L
    Eur Neurol; 1977; 15(2):71-6. PubMed ID: 323018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?
    Drakatos P; Leschziner G
    J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irregular sleep-wake rhythm disorder Masquerading as hypersomnia in Moebius syndrome.
    McCarter SJ; Auger RR; Ruoff CM; St Louis EK
    Sleep Med; 2023 Mar; 103():14-15. PubMed ID: 36724567
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
    Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel method for evaluation of eye movements in patients with narcolepsy.
    Christensen JAE; Kempfner L; Leonthin HL; Hvidtfelt M; Nikolic M; Kornum BR; Jennum P
    Sleep Med; 2017 May; 33():171-180. PubMed ID: 28087252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome.
    Koerber RK; Torkelson R; Haven G; Donaldson J; Cohen SM; Case M
    Neurology; 1984 Dec; 34(12):1597-600. PubMed ID: 6209595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in the characteristics of subjective and objective sleepiness between narcolepsy and essential hypersomnia.
    Komada Y; Inoue Y; Mukai J; Shirakawa S; Takahashi K; Honda Y
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):194-9. PubMed ID: 15823167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders of excessive sleepiness: narcolepsy and hypersomnia.
    Manfredi RL; Brennan RW; Cadieux RJ
    Semin Neurol; 1987 Sep; 7(3):250-8. PubMed ID: 3332460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.